Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer

Stopped early · Not applicable

Conditions studied: Breast Cancer, Lymphedema

In brief

RATIONALE: The Flexitouch lymphedema system may lessen lymphedema caused by treatment for breast cancer. It is not yet known whether the Flexitouch lymphedema system is more effective than complex decongestive therapy in treating lymphedema. PURPOSE: This randomized clinical trial is studying the Flexitouch lymphedema system in treating stage II lymphedema in patients with breast cancer.

Key facts

Study ID

NCT01019512

Run by

Abramson Cancer Center at Penn Medicine

People needed

60

Starts

2009-07-01

Last updated by the study team

2015-03-25

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Abramson Cancer Center of The University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.